Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
Pharmacopsychiatry
    November 2024
  1. FERNANDO P, Strauss J, Wagner E, Lohrs L, et al
    Early Treatment-Resistance in First Episode Psychosis.
    Pharmacopsychiatry. 2024 Nov 15. doi: 10.1055/a-2421-2411.
    >> Share

  2. QU K, He Y, Zhang Z, Cao Y, et al
    Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment.
    Pharmacopsychiatry. 2024;57:283-289.
    >> Share

  3. DEN TOOM M, Blanken L, Horn I, Veerman S, et al
    Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, Randomized-Controlled Feasibility Trial.
    Pharmacopsychiatry. 2024;57:290-295.
    >> Share

    May 2024
  4. KOMATSU Y, Takehara M, Hart X, Takahashi Y, et al
    Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments.
    Pharmacopsychiatry. 2024 May 6. doi: 10.1055/a-2307-6484.
    >> Share

    April 2024
  5. LLORCA-BOFI V, Bioque M, Madero S, Mallorqui A, et al
    Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naive, Schizophrenia-Spectrum Disorder.
    Pharmacopsychiatry. 2024 Apr 15. doi: 10.1055/a-2290-6386.
    >> Share

    February 2024
  6. HART XM, Mitsukura Y, Bies RR, Uchida H, et al
    Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis.
    Pharmacopsychiatry. 2024 Feb 22. doi: 10.1055/a-2258-0379.
    >> Share

    January 2024
  7. BREIT S, Meyer A, Schmitt W, Bracht T, et al
    The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response.
    Pharmacopsychiatry. 2024;57:13-20.
    >> Share

    July 2023
  8. WAGNER E, Strube W, Gorlitz T, Aksar A, et al
    Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial.
    Pharmacopsychiatry. 2023 Jul 28. doi: 10.1055/a-2110-4259.
    >> Share

    May 2023

  9. [Not Available].
    Pharmacopsychiatry. 2023;56:127.
    >> Share

    March 2023
  10. SPOOV J
    The Mini-TRH Test.
    Pharmacopsychiatry. 2023;56:51-56.
    >> Share

  11. BARTSCH JC, Schott BH, Behr J
    Hippocampal Dysfunction in Schizophrenia and Aberrant Hippocampal Synaptic Plasticity in Rodent Model Psychosis: a Selective Review.
    Pharmacopsychiatry. 2023;56:57-63.
    >> Share

    November 2022
  12. AGUGLIA A, Fusar-Poli L, Natale A, Amerio A, et al
    Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study.
    Pharmacopsychiatry. 2022;55:281-289.
    >> Share

    July 2022
  13. COLIJN MA
    The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms.
    Pharmacopsychiatry. 2022 Jul 11. doi: 10.1055/a-1882-6802.
    >> Share

  14. KISHI T, Sakuma K, Iwata N
    Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis.
    Pharmacopsychiatry. 2022 Jul 5. doi: 10.1055/a-1860-2793.
    >> Share

  15. LOPEZ-MORINIGO JD, Leucht S, Arango C
    Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
    Pharmacopsychiatry. 2022 Jul 1. doi: 10.1055/a-1854-0185.
    >> Share

    June 2022
  16. ESEN-SEHIR D, Kopf J, Hagele S, Plichta MM, et al
    Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia.
    Pharmacopsychiatry. 2022 Jun 22. doi: 10.1055/a-1811-7241.
    >> Share

    May 2022
  17. MIURA G, Tanaka K, Kemuriyama T, Misawa F, et al
    Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review.
    Pharmacopsychiatry. 2022 May 5. doi: 10.1055/a-1811-7318.
    >> Share

    January 2022
  18. VEERMAN SRT, Bogers JPAM, Cohen D, Schulte PFJ, et al
    COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine.
    Pharmacopsychiatry. 2022;55:48-56.
    >> Share

    May 2021
  19. SPOOV J, Bredbacka PE
    Failing Memory in Nonaffective Psychosis and Prolactin Response to 12.5 microg i.v. TRH.
    Pharmacopsychiatry. 2021 May 12. doi: 10.1055/a-1481-9058.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016